Dexamethasone changes the pharmacokinetics of amitriptyline and reduces its accumulation in rat brain: The roles of P-gp and cyp3a2
The wide spread use of central nervous system (CNS) drugs has caused thousands of deaths in clinical practice while there are few antidotes or effective treatments to decrease their accumulation in CNS. In this study, we used amitriptyline (AMI) and dexamethasone (DEX) as the corresponding poisoning...
Main Authors: | Jing Wen, Yuan Shen, Min Zhang, Chao Wang, Yalan Xiang, Hualin Cai, Pingfei Fang, Huande Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-05-01
|
Series: | Journal of Pharmacological Sciences |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861319310527 |
Similar Items
-
Clinical pharmacokinetics of amitriptyline and nortriptyline in relation to CYP2D6 mediated metabolism
by: Ghahramani, Parviz
Published: (1998) -
Pharmacokinetics and Efficacy of Fluvoxamine and Amitriptyline in Depression
by: Sandra Vezmar, et al.
Published: (2009-01-01) -
Effects of Genetic Polymorphism in CYP2D6, CYP2C19, and the Organic Cation Transporter OCT1 on Amitriptyline Pharmacokinetics in Healthy Volunteers and Depressive Disorder Patients
by: Johannes Matthaei, et al.
Published: (2021-05-01) -
THE IMPACT OF CYP3A4*22 AND CYP3A5*3 ON DEXAMETHASONE AND 6-HYDROXY-DEXAMETHASONE PHARMACOKINETICS IN PHASE 1/2 CANCER PATIENTS
by: He, Lei
Published: (2013) -
Effect of herb-drug interactions of Bacopa monnieri Linn. (Brahmi) formulation on the pharmacokinetics of amitriptyline in rats
by: Fowad Khurshid, et al.
Published: (2018-03-01)